Proteasome Inhibition Sensitizes Hepatocellular Carcinoma Cells, But Not Human Hepatocytes, to TRAIL *
Tom M. Ganten(German Cancer Research Center), Henning Walczak(CRUK Lung Cancer Centre of Excellence)
Cited by 171
Related Papers
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Getting TRAIL back on track for cancer therapy
|Cell Death and Differentiation|2014|453
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma
|Transplantation|2015|417
Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling
|Trends in Cell Biology|2016|175